EUCTR2019-002027-15-FR进行中（未招募）1 期
/A - PAC CEF
CHU DE NIMES0 个研究点目标入组 12 人开始时间: 2019年7月2日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 12
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 12
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
A Phase 1/Phase 2 Trial to Evaluate Safety, Immunogenicity and PSA Response of VTP-850 Prostate Cancer Immunotherapeutic in Men with Biochemical Recurrence after Definitive Local Therapy for Prostate CancerProstate CancerCTIS2023-504066-39-00Vaccitech PLC117
进行中（未招募）
1 期
/AEUCTR2015-000492-27-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)120
已完成
不适用
APC & BehaviourAttention disorder1001801810009841NL-OMON41579Academisch Medisch Centrum100
进行中（未招募）
1 期
A Phase I Study to Evaluate Safety and Immunogenicity of DNA Vaccine N-pVAX1 against Crimean Congo Hemorrhagic Fever (CCHF-NP-1)Crimean Congo Hemorrhagic FeverMedDRA version: 20.1Level: PTClassification code: 10010685Term: Congo-Crimean haemorrhagic fever Class: 100000004862CTIS2023-508556-18-00Karolinska Institutet15
进行中（未招募）
1 期
Single dose, open-label, laboratory blinded, randomised, 2-treatment, 2-period, 2-sequence, crossover bioequivalence study of test product Perampanel 2 mg film-coated tablets versus reference product Fycompa 2 mg film-coated tablets (Eisai GmbH) in healthy adult male and female subjects under fasting conditions..A. (submitted trial is a bioequivalence study in healthy human subjects)MedDRA version: 20.0Level: HLGTClassification code: 10039911Term: Seizures (incl subtypes) Class: 10029205CTIS2023-504132-18-00aboratorios Cinfa S.A.36